Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries ANI Pharma Inc (NQ: ANIP ) 58.30 +1.02 (+1.78%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about ANI Pharma Inc < Previous 1 2 3 Next > ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger September 11, 2024 From ANI Pharmaceuticals, Inc. and Alimera Sciences, Inc. Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Morphic Holding, Inc. (Nasdaq - MORF), Desktop Metal, Inc. (NYSE - DM), Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR) July 08, 2024 From Brodsky & Smith LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR), PlayAGS, Incorporated (NYSE - AGS), RBAZ Bancorp, Inc. (OTCPK - RBAZ) July 01, 2024 From Brodsky & Smith LLC Via GlobeNewswire ANI Pharmaceuticals Inc. (NASDAQ: ANIP) Records 52-Week High Wednesday Morning August 23, 2023 Via Investor Brand Network ANI Pharmaceuticals to Present at the Jefferies Healthcare Conference May 22, 2023 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares May 16, 2023 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals Announces FDA Approval and Commercialization of Two ANDAs with CGT Exclusivity May 15, 2023 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals Announces Pricing of $75 Million Public Offering of Common Stock May 12, 2023 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals Announces Proposed Public Offering of Common Stock May 11, 2023 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance May 08, 2023 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals to Discuss First Quarter 2023 Financial Results on May 8, 2023, at 8:30 a.m. ET April 27, 2023 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ April 26, 2023 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals Announces the FDA Approval and Launch of Nitrofurantoin Oral Suspension USP April 24, 2023 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals Announces the FDA Approval of Colestipol Hydrochloride Tablets USP April 04, 2023 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals Reports Record Fourth Quarter Financial Results and Achieves Full Year 2022 Revenue Milestone; Initiates 2023 Guidance March 09, 2023 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023, at 8:30 a.m. ET February 22, 2023 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals Announces the FDA Approval and Launch of Levocarnitine Tablets USP December 19, 2022 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals Announces the FDA Approval and Launch of Fluoxetine Oral Solution USP November 28, 2022 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals Announces the FDA Approval and Launch of Trimethoprim Tablets USP November 16, 2022 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals Reports Third Quarter 2022 Financial Results; Reports Record Net Revenues November 09, 2022 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals to Discuss Third Quarter 2022 Financial Results on November 9, 2022, at 8:00 a.m. ET October 24, 2022 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals Appoints Krista Davis as Chief Human Resources Officer September 12, 2022 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference August 30, 2022 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals Announces the Launch of Prochlorperazine Maleate Tablets USP August 29, 2022 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Dexamethasone Tablets USP August 16, 2022 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results; Reports Record Net Revenues and Raises Full-Year 2022 Net Revenue Guidance for Purified Cortrophin® Gel August 08, 2022 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals Announces the Launch of Acebutolol Hydrochloride Capsules USP August 03, 2022 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals Acquires ANDAs from Oakrum Pharma, LLC July 28, 2022 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET July 25, 2022 From ANI Pharmaceuticals, Inc. Via Business Wire ANI Pharmaceuticals Appoints Meredith W. Cook as SVP, General Counsel and Corporate Secretary July 18, 2022 From ANI Pharmaceuticals, Inc. Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.